Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia

BACKGROUND: miRNA 223 /125a and Cordon-bleu Protein Like 1 (COBLL1) are novel biomarkers that can predict prognosis and guide treatment decisions in patients with chronic lymphocytic leukemia (CLL). Also, there is a growing interest in CLL monitoring based on flow cytometry of receptor tyrosine kina...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Samia, Abdelazem, Abdallah S., Abdelmoneem, Shimaa, Abdelnabi, AL-Shabrawy M., Khamis, Tarek, Obaya, Ahmed Ali, Ebian, Huda F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741902/
https://www.ncbi.nlm.nih.gov/pubmed/36037128
http://dx.doi.org/10.31557/APJCP.2022.23.8.2735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741902/
https://www.ncbi.nlm.nih.gov/pubmed/36037128
http://dx.doi.org/10.31557/APJCP.2022.23.8.2735

Ejemplares similares